v3.22.0.1
Stockholders’ Equity (Deficit) - Summary of Option and RSU Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Shares Available for Grant    
Balances at beginning of period (in shares) 86,420,000 25,344,000
Granted (in shares) (9,591,000) (45,368,000)
Increase in shares available for grant (in shares)   66,942,000
Shares withheld for taxes (in shares) 464,000 24,296,000
Exercised/Vested (in shares) 0 0
Canceled (in shares) 4,072,000 15,206,000
Balances at end of period (in shares) 81,365,000 86,420,000
Number of Shares    
Balances at beginning of period (in shares) 41,421,000 46,512,000
Granted (in shares) 715,000 4,638,000
Increase in shares available for grant (in shares)   0
Shares withheld for taxes (shares) 0 0
Exercised/Vested (in shares) (17,707,000) (7,496,000)
Canceled (in shares) (307,000) (2,233,000)
Balances at end of period (in shares) 24,122,000 41,421,000
Weighted- Average Exercise Price    
Balances at beginning of period (in USD per share) $ 12.48 $ 10.08
Granted (in USD per share) 191.08 39.38
Increase in shares available for grant (in USD per share)   0
Shares withheld for taxes (in USD per share) 0 0
Exercised/Vested (in USD per share) 7.77 2.01
Canceled (in USD per share) 56.69 53.32
Balances at end of period (in USD per share) $ 19.69 $ 12.48
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Options outstanding (in shares) 24,122,000 41,421,000
Options exercisable (in shares) 20,909,000 36,682,000
Options outstanding (in USD per share) $ 19.69 $ 12.48
Options excisable (in USD per share) $ 13.28 $ 8.63
Options outstanding, weighted-average remaining contractual life (in years) 3 years 7 months 28 days 3 years 10 months 28 days
Options exercisable, weighted-average remaining contractual life (in years) 2 years 10 months 24 days 3 years 2 months 15 days
Options outstanding, aggregate intrinsic value $ 3,555,384 $ 5,563,735
Options exercisable, aggregate intrinsic value $ 3,206,548 $ 5,068,315
2020 Plan | Common Class A    
Shares Available for Grant    
Increase in shares available for grant (in shares)   62,069,613
Assumed Equity Incentive Plan    
Number of Shares    
Canceled (in shares) (2,158) (55,158)
Assumed Equity Incentive Plan | Common Class A    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Options exercisable (in shares) 98,093 150,816
Options excisable (in USD per share) $ 22.67 $ 22.61
Restricted stock units    
Number of Shares    
Balances at beginning of period (in shares) 47,754,000 76,136,000
Granted (in shares) 8,876,000 40,730,000
Shares withheld for taxes (in shares) (464,000) 0
Vested (in shares) (15,612,000) (56,070,000)
Canceled (in shares) (3,765,000) (13,042,000)
Balances at end of period (in shares) 36,789,000 47,754,000
Weighted-Average Grant-Date  Fair Value Per Share    
Balances at beginning of period (in USD per share) $ 40.01 $ 45.69
Granted (in USD per share) 181.15 30.13
Increase in shares available for grant (in USD per share)   $ 0
Increase in shares available for grant (in shares)   0
Shares withheld for taxes (in USD per share) 66.99 $ 0
Vested (in USD per share) 57.05 37.79
Canceled (in USD per share) 64.32 51.86
Balances at end of period (in USD per share) $ 61.22 $ 40.01
Restricted stock units | Assumed Equity Incentive Plan    
Number of Shares    
Canceled (in shares) (530) (14,178)